What are the symptoms and laboratory findings of myocarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Myocarditis: Clinical Symptoms and Laboratory Findings

Myocarditis presents with a triad of cardiac symptoms, elevated cardiac troponin, and abnormal cardiac testing (ECG, echocardiography, or cardiac MRI), with chest pain being the most common symptom occurring in 82-95% of adult patients. 1, 2

Clinical Symptoms

Cardinal Presenting Symptoms

  • Chest pain is the predominant symptom, occurring in 82-95% of adult patients with acute myocarditis, often mimicking acute coronary syndrome with angina-like quality 3, 2
  • Dyspnea presents in 19-49% of cases, ranging from mild exertional breathlessness to acute heart failure 1, 3, 2
  • Fever is among the most common symptoms, particularly with viral myocarditis including COVID-19 1, 3
  • Cough frequently accompanies viral myocarditis, especially in respiratory viral infections 1, 3

Additional Cardiac Symptoms

  • Palpitations from supraventricular or ventricular tachyarrhythmias are common 1, 3
  • Syncope occurs in 5-7% of patients, often related to arrhythmias or hemodynamic compromise 1, 3, 2
  • Postexertional fatigue is a characteristic symptom that may persist long-term 1, 3
  • Nonspecific chest discomfort beyond typical angina, including pressure sensations 1, 3

Temporal Pattern and Severity Spectrum

  • Recent viral illness with gastrointestinal or upper respiratory symptoms often precedes cardiac symptoms by days to weeks 3
  • Symptoms typically evolve over days to weeks during the inflammatory phase 1, 3
  • Resolution within 3 months occurs in many cases, though persistence beyond 12 months has been documented indicating chronic myocarditis 1, 3
  • Acute congestive heart failure with or without cardiogenic shock can occur 1
  • Cardiogenic shock develops in 27% of COVID-19-associated myocarditis cases 3, 4

Laboratory Findings

Cardiac Biomarkers

  • Elevated cardiac troponin (preferably using a high-sensitivity assay) above the 99th percentile upper reference limit is a defining feature of myocarditis 1, 3
  • Troponin elevation is required for diagnosis but correlates poorly with the degree of systolic dysfunction 4
  • Creatine kinase may also be elevated, indicating myocyte necrosis 1

Electrocardiographic Findings

  • Diffuse T-wave inversion without reciprocal changes 1, 3
  • ST-segment elevation without reciprocal ST-segment depression, mimicking acute myocardial infarction 1
  • Prolongation of the QRS complex duration 1
  • Supraventricular and ventricular tachyarrhythmias are common 1
  • Bradyarrhythmias and intraventricular conduction delays, including advanced atrioventricular block 1, 3

Echocardiographic Findings

  • Left ventricular wall motion abnormalities in a noncoronary distribution 1, 3
  • Wall thickening may be present 2
  • Systolic dysfunction ranging from subclinical abnormal strain patterns to overt heart failure 4
  • Right ventricular dysfunction is common, with fractional area change <35% 4

Cardiac MRI Findings (Definitive Diagnosis)

  • Nonischemic late gadolinium enhancement (LGE) pattern, typically subepicardial or mid-myocardial rather than endocardial 1, 4, 5
  • Prolonged native T1 relaxation times (>2 standard deviations above local reference mean) indicating inflammation/edema 1, 4, 5
  • Prolonged T2 relaxation times (>2 standard deviations above local reference mean) indicating myocardial edema 1, 4, 5
  • Elevated extracellular volume (ECV) >30% suggesting interstitial/extracellular space involvement 4
  • Updated Lake Louise Criteria requires at least one T2-based criterion and at least one T1-based criterion for high specificity diagnosis 5

Diagnostic Certainty Levels

The American College of Cardiology categorizes myocarditis into three levels of diagnostic certainty 1:

Possible Myocarditis

  • Cardiac symptoms present 1
  • Elevated cardiac troponin 1
  • Abnormal ECG and/or echocardiographic findings 1
  • But either CMR/biopsy not performed or shows no acute myocarditis 1

Probable Myocarditis

  • All features of possible myocarditis present 1
  • Follow-up CMR and/or biopsy within 6 months demonstrates abnormalities consistent with previous myocarditis 1

Definite Myocarditis

  • All features of possible myocarditis present 1
  • CMR and/or biopsy performed at time of acute illness demonstrates findings consistent with active myocarditis 1

Critical Diagnostic Pitfalls

  • Symptom intensity does not correlate with ejection fraction severity - patients may have severely reduced LVEF with minimal symptoms or vice versa 4
  • Cardiac biomarkers correlate poorly with the degree of systolic dysfunction - elevated troponin does not predict severity of ventricular dysfunction 4
  • Flow-limiting coronary artery disease must be excluded, ideally in men older than 50 years and women older than 55 years 1
  • CMR has lower sensitivity for chronic myocarditis (>14 days from symptom onset), with diagnostic accuracy dropping from 81% in acute cases to 45% in chronic cases 5
  • Multiple etiologies may coexist, making it challenging to identify a specific underlying cause 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Viral Myocarditis Symptoms and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Differentiating Normal Reduction in Ejection Fraction from Viral Myocarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Role of Cardiac MRI in Diagnosing and Treating Myocarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.